Guardant Health Statistics

Total Valuation

Guardant Health has a market cap or net worth of EUR 11.43 billion. The enterprise value is 11.84 billion.

Market Cap	11.43B
Enterprise Value	11.84B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	130.64M
Shares Outstanding	n/a
Shares Change (YoY)	+2.14%
Shares Change (QoQ)	+3.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	124.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.67
PB Ratio	-135.16
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-33.40
EV / Sales	14.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.84

Current Ratio	4.84
Quick Ratio	4.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-111.44

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-15.51%
Return on Invested Capital (ROIC)	-19.53%
Return on Capital Employed (ROCE)	-25.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	416,113
Profits Per Employee	-176,390
Employee Count	2,010
Asset Turnover	0.56
Inventory Turnover	4.45

Taxes

Income Tax	-1.08M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +102.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+102.44%
50-Day Moving Average	90.32
200-Day Moving Average	62.55
Relative Strength Index (RSI)	54.63
Average Volume (20 Days)	37

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.73

Income Statement

In the last 12 months, Guardant Health had revenue of EUR 836.39 million and -354.54 million in losses. Loss per share was -2.83.

Revenue	836.39M
Gross Profit	539.14M
Operating Income	-369.88M
Pretax Income	-355.62M
Net Income	-354.54M
EBITDA	-336.17M
EBIT	-369.88M
Loss Per Share	-2.83

Full Income Statement

Balance Sheet

The company has 1.02 billion in cash and 1.43 billion in debt, with a net cash position of -409.55 million.

Cash & Cash Equivalents	1.02B
Total Debt	1.43B
Net Cash	-409.55M
Net Cash Per Share	n/a
Equity (Book Value)	-84.58M
Book Value Per Share	-0.65
Working Capital	990.80M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 64.46%, with operating and profit margins of -44.22% and -42.39%.

Gross Margin	64.46%
Operating Margin	-44.22%
Pretax Margin	-42.52%
Profit Margin	-42.39%
EBITDA Margin	-40.19%
EBIT Margin	-44.22%
FCF Margin	n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.14%
Shareholder Yield	-2.14%
Earnings Yield	-3.10%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guardant Health has an Altman Z-Score of 0.46 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	3